June 6, 2012
/PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading
-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that 3SBio will attend the Bank of America Merrill Lynch HK / China Healthcare Corporate Day in
June 8, 2012
. A copy of 3SBio's investor presentation material for the conference is available at
About 3SBio Inc.
3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in
, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see
for more information.
Chief Financial Officer3SBio Inc.Tel: + 86 24 2581-1820
Director of Investor Relations3SBio Inc. Tel: + 852 8191-6991
SOURCE 3SBio Inc.